Hexagon Nutrition Ltd (HEXAGON) is currently trading at 61.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Hexagon Nutrition Limited is a research‑oriented, pure‑play nutrition company manufacturing micronutrient premixes, clinical and therapeutic nutrition, ready‑to‑use foods, and branded consumer nutrition products marketed under brands such as PentaSure, Pediagold, Obesigo and NUTRONE, with manufacturing facilities in Nashik, Chennai (MEPZ) and Thoothukudi and an export footprint across more than 70 countries. Q1 FY27 consolidated revenue was INR104.3 crores, up 43.2% year‑on‑year, with EBITDA of INR11.8 crores and PAT of INR8.1 crores; however EBITDA margin contracted to 11.3% from 13.8% year‑ago, reflecting a combination of raw material, freight inflation and strategic sales/marketing investments during the quarter. Management reports blended capacity utilization rising to roughly 47% in Q1 (with Nashik around 55%–60%, Chennai 25%–30%, Tuticorin 35%–40%), and a disclosed order book of INR100 crores largely executable across Q2 and Q3—providing short‑term revenue visibility and supporting the company’s targeted FY27 growth trajectory. The company is prioritizing branded portfolio expansion, geographic diversification of exports, R&D driven product development and selective capex (INR25–30 crores for Nashik redevelopment), positioning Hexagon Nutrition Limited to scale branded revenue from about 28% currently toward a targeted ~35% mix over the next couple of years.

Over the past 52 weeks, Hexagon Nutrition Ltd has traded between a low of ₹48.00 and a high of ₹78.69. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Hexagon Nutrition Ltd has a market capitalization of approximately 756.81. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Hexagon Nutrition Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.10 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 756.81 Cr, Hexagon Nutrition Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Hexagon Nutrition Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Hexagon Nutrition Ltd is 21.10. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The board meeting is scheduled for September 30, 2026, and will consider requisitions related to a director appointment (Executive Director and Chairman) and approval of executive remuneration, along with other business matters.

The Board recommended a final dividend of ₹0.30 per equity share (face value ₹1) for the financial year ended March 31, 2026.

In Q1 FY27 (consolidated), revenue from operations rose 43.2% YoY to ₹1,043.06 million and net profit increased 25.1% YoY to ₹80.73 million.

Hexagon Nutrition is scheduled to list on Friday, June 12, 2026, on both BSE and NSE.